LGT Fund Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.7M Buy
213,831
+108,315
+103% +$8.74M 0.7% 28
2026
Q1
$9.14M Buy
105,516
+78,728
+294% +$7.54M 0.4% 58
2025
Q4
$2.59M Sell
26,788
-1,732
-6% -$168K 0.2% 114
2025
Q3
$2.7M Hold
28,520
0.22% 114
2025
Q2
$2.49M Hold
28,520
0.22% 112
2025
Q1
$2.56M Sell
28,520
-3,427
-11% -$307K 0.23% 105
2024
Q4
$2.55M Buy
31,947
+6,722
+27% +$582K 0.22% 101
2024
Q3
$2.25M Buy
25,225
+1,275
+5% +$107K 0.23% 94
2024
Q2
$1.89M Buy
+23,950
New +$1.96M 0.23% 87
2022
Q3
Sell
-61,237
Closed -$5.5M 155
2022
Q2
$5.5M Buy
61,237
+9,699
+19% +$983K 0.81% 28
2022
Q1
$5.8M Buy
+51,538
New +$5.44M 0.77% 28

Other funds holding MDT

LGT Fund Management's MDT Position: Q2 2026 in Review

LGT Fund Management increased its Medtronic (MDT) stake by 103% in Q2 2026, buying an estimated $8.74M and bringing the position to 213,831 shares worth $16.7M. The position accounts for 0.7% of the portfolio, ranked #28.

LGT Fund Management first reported a position in MDT in Q1 2022 and has held it in 11 quarters since. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • LGT Fund Management held 213,831 shares of Medtronic worth $16.7M as of Q2 2026.
  • LGT Fund Management bought 108,315 Medtronic shares in Q2 2026, an estimated $8.74M.
  • Medtronic made up 0.7% of LGT Fund Management's portfolio in Q2 2026, its #28 holding.
  • LGT Fund Management first reported a position in Medtronic in Q1 2022 and has held it in 11 quarters since.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on LGT Fund Management's 13F filing for Q2 2026, filed 10 Aug 2026.